Sign inJoin waitlistJoin the waitlist

Joanna Yang

Clinical Residency Program Director · Washington University/B-JH/SLCH Consortium

Credentials: · · · · · ·

History

Clinical Residency · Washington University/B-JH/SLCH Consortium
Present
Education · Washington University/B-JH/SLCH Consortium
Present
Leukemia and Lymphoma Service Division · Washington University/B-JH/SLCH Consortium
Present

Radiation Oncology
Memorial Sloan Kettering Cancer Center
2014–2018
Preliminary or Transitional Year
2013–2014
Harvard School of Public Health (Boston, MA
Icahn School of Medicine at Mount Sinai
2009–2013
Stanford University (Stanford, CA
2005–2009

Research

Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial
Journal of Clinical Oncology · 2024 · 97 citations
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Journal of the National Comprehensive Cancer Network · 2022 · 71 citations
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Blood · 2016 · 57 citations

Joachim Yahalom
17 papers
Bouthaina Dabaja
6 papers
SW
Suzanne Wolden
6 papers
AZ
Andrew Zelenetz
5 papers
PH
Paul Hamlin
5 papers
AN
Ariela Noy
4 papers
Craig Moskowitz
4 papers
Heiko Schöder
4 papers
Jillian Gunther
4 papers
JP
John Plastaras
4 papers
Karen Chau
4 papers
Lia Palomba
4 papers

Clinical trials

Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Principal investigator · Completed
Washington University School of Medicine
2024–2025
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
Site PI · Recruiting
Society of Interventional Oncology
2025–2027
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Sub-investigator · Recruiting · Phase 1
Washington University School of Medicine
2024–2028
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
2024–2034